AMASS Expands into Protein Beverage Market with Majority Stake in HpO
Money

AMASS Expands into Protein Beverage Market with Majority Stake in HpO

authorBy T. Harv Eker
DateJun 29, 2026
Read Time3 min

AMASS Brands Group is making a strategic move into the burgeoning protein beverage market by announcing its intention to acquire a controlling interest in HpO, a brand specializing in sparkling protein water. This acquisition will significantly boost AMASS's stake in HpO from a prior 15% to a commanding majority of approximately 50.0001% on a fully diluted basis. The deal underscores AMASS's commitment to capitalizing on the escalating consumer preference for functional hydration options, particularly those rich in protein, a trend further amplified by the increasing adoption of GLP-1 weight-loss medications.

The transaction not only secures AMASS a majority holding but also includes a forward-looking option to purchase the outstanding shares of HpO within a three-year timeframe, with the purchase price set at twice HpO's revenue. This financial arrangement, while not fully detailed beyond the stock-based consideration, positions AMASS to fully integrate HpO into its portfolio, leveraging the brand's potential within a market projected to nearly double in value over the next decade. The expansion strategy is poised to enhance AMASS's market presence and diversify its offerings in response to evolving consumer health and wellness trends.

Strategic Investment in the High-Growth Protein Beverage Sector

AMASS Brands Group's decision to acquire a majority stake in HpO, a sparkling protein water company, marks a pivotal moment for the firm, aligning it with a rapidly expanding segment of the functional beverage market. This move is designed to meet the escalating consumer demand for protein-enriched and health-conscious drink options. HpO's product, featuring plant-based protein, zero sugar, and minimal calories, perfectly caters to current dietary preferences, including those influenced by GLP-1 weight-loss medications that encourage high-protein, low-sugar consumption. By bolstering its presence in this dynamic market, AMASS aims to solidify its competitive edge and tap into a significant growth opportunity within the wellness industry.

The acquisition strategically positions AMASS to capitalize on the substantial growth predicted for the U.S. protein water market, which is forecast to reach almost $2 billion by 2034 from an estimated $861 million in 2024. This market expansion is largely driven by evolving consumer health trends and the increasing popularity of dietary supplements. AMASS's CEO, Mark Thomas Lynn, emphasized the dual appeal of HpO's offerings, noting their resonance with consumers seeking convenient protein sources and those managing their weight with GLP-1 medications. The strategic timing of this investment underscores AMASS's foresight in identifying and leveraging key market drivers for long-term growth and portfolio diversification.

AMASS's Vision for National Market Penetration and Portfolio Expansion

Following its acquisition of a majority stake in HpO, AMASS Brands Group is poised to initiate a comprehensive national expansion strategy, aiming to significantly broaden HpO's market reach. This strategic initiative will harness AMASS's established wholesale distribution networks and existing retail partnerships, facilitating widespread availability of HpO's innovative sparkling protein water products. The expansion is a critical component of AMASS's broader vision to cultivate a diverse portfolio across various emerging beverage categories, mirroring its recent investment in Afterdream, a hemp-derived THC beverage brand. This multifaceted approach underscores AMASS's commitment to strategic growth and market leadership.

The financial framework of the HpO acquisition involves funding through AMASS common stock, with its valuation based on the trailing 21-day volume-weighted average price at the point of closing. This financial arrangement, contingent upon definitive agreements and standard closing conditions, highlights AMASS's disciplined approach to mergers and acquisitions. Concurrently, AMASS Brands shares have shown positive market response, reflecting investor confidence in these strategic maneuvers. This strategic acquisition and planned expansion are expected to not only enhance HpO's national footprint but also significantly contribute to AMASS's overall growth trajectory and market influence in the evolving beverage landscape.

More Articles
Money
Atai Capital Management's Investment Journey with AstroNova (ALOT)
Atai Capital Management recently shared its Q1 2026 investor letter, detailing its portfolio's strong performance with a 6.6% return, outperforming major indices. The firm highlighted AstroNova, Inc. (ALOT), a company specializing in printers and data systems, which was recently acquired for $29 per share. Atai's long-term investment in AstroNova, despite initial challenges from a problematic acquisition, ultimately yielded significant benefits due to new management's strategic improvements.
By Scott PapeJun 29, 2026
Money
Meridian Hedged Equity Fund Maintains Position in Microsoft Amidst Market Shifts
Meridian Hedged Equity Fund's first-quarter 2026 investor letter reveals its performance against market benchmarks, particularly its continued investment in Microsoft Corporation (MSFT). Despite a challenging market influenced by geopolitical events and changing interest rate expectations, the fund outperformed the S&P 500 and CBOE S&P 500 BuyWrite Index, highlighting its strategic hedging approach. The fund maintains a strong conviction in Microsoft's long-term growth driven by its leadership in cloud computing and generative AI.
By Ramit SethiJun 29, 2026
Money
Barclays Raises Price Target for Canadian National Railway Amidst Positive Market Shifts
Barclays has increased its price target for Canadian National Railway (CNI) to $109, maintaining an Equal Weight rating. This adjustment reflects an improved outlook for the North American transportation sector, driven by robust domestic and international freight demand, reduced capacity, and growing U.S. imports. RBC Capital also revised its CNI target to C$195 with an Outperform rating, highlighting strong volumes and favorable network dynamics.
By Natalie PaceJun 29, 2026
Money
JPMorgan Chase: A Resilient Banking Giant for Long-Term Investors
JPMorgan Chase stands as a robust choice for retirement-focused investors due to its unparalleled scale, diversification, and strong capital reserves. With $4.9 trillion in assets and a leading position in global investment banking, its operational breadth is unmatched. The bank consistently returns capital to shareholders through dividends and buybacks, demonstrating resilience through economic downturns and delivering substantial long-term returns. Its proven ability to navigate various market conditions makes it a stable and compounding asset.
By Scott PapeJun 29, 2026
Money
Ipsen Acquires Kartos Therapeutics in Major Biopharma Deal
Ipsen has completed the acquisition of Kartos Therapeutics for a potential total of $1.75 billion, including an initial payment of $450 million and future milestone payments. This strategic move aims to enhance Ipsen's late-stage oncology pipeline with navtemadlin, a promising treatment for myelofibrosis, a rare blood cancer. The drug is currently in a global Phase III trial, with results anticipated in 2027, and is expected to contribute to Ipsen's operating income by 2029.
By T. Harv EkerJun 29, 2026